Lobbying Filing Details
Total Spending
$60,000
Activities
1
Lobbyists
1
Gov't Entities
5
Filing Information
- Filing UUID:
d9a3bd4a-35d0-4e12-a81f-d477bb0bd5a6- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2023 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 19, 2023 at 1:12 AM
- Income:
- $0
- Expenses:
- $60,000
- Expense Method:
- A
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: John Allen
Registrant
INOVIO PHARMACEUTICALS, INC.
Plymouth Meeting, PennsylvaniaClient
INOVIO PHARMACEUTICALS, INC.
Biotechnology company
Pennsylvania, United States of AmericaLobbying Activities (1)
Activity 1
Health IssuesIssues related to Recurrent Respiratory Papillomatosis (RRP), an HPV associated disease; Issues related to the Orphan Drug Act and orphan drug destination; Issues related to the Orphan Drug Tax Credit; Issues related to Accelerated Approval reforms and accelerated approval pathway at FDA and decentralized trials; Issues related to CMS IRA implementation and small biotech exemption; Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Next Generation COVID-19 vaccines and boosters; Issues related to ASPR/BARDA and manufacturing of pan-coronavirus vaccines and boosters; Issues related to Oncology and HPV cancers and other associated diseases; Issues related to medical devices and cybersecurity issues; Issues related to Transitional Coverages of Emerging Technologies (TCET) and medical devices; Issues related to FY2024 Labor, Health and Human Services and Education Annual Appropriations; DNA Medicines Platform Technology awareness
Lobbyists (1)
- MS. COOKAB HASHEMI
Government Entities (5)
- SENATE
- HOUSE OF REPRESENTATIVES
- White House Office
- Defense, Dept of (DOD)
- Health & Human Services, Dept of (HHS)